Literature DB >> 14757202

Production of monoclonal antibodies capable of neutralizing dermonecrotic activity of Loxosceles intermedia spider venom and their use in a specific immunometric assay.

Larissa M Alvarenga1, Maria S Martins, Juliana F Moura, Evanguedes Kalapothakis, Júlio C Oliveira, Oldemir C Mangili, Claude Granier, Carlos Chávez-Olórtegui.   

Abstract

We have produced 13 mAbs for Loxosceles intermedia crude venom. Twelve were reactive against proteins of 32-35 kDa and one of these Li mAb(7) showed high neutralizing potency for the dermonecrotic activity of L. intermedia venom. This Li mAb(7) showed no cross-reactivity, with Loxosceles laeta (Brazil), L. laeta (Perú) and Loxosceles gaucho venoms. The mAbs were produced by immunization with the crude venom and screened by enzyme-linked immunosorbent assay (ELISA) using L. intermedia whole venom or dermonecrotic fraction (DNF) as antigens coated onto microtitre plates. A sensitive two-site immunometric assay was designed and shown to be useful for identifying and quantifying DNF from L. intermedia in biological samples. The Li mAb(7) coated onto microtitre plates and hyperimmune horse anti-L. intermedia IgGs prepared by immunoaffinity chromatography and conjugated to horseradish peroxidase were used to set up a sandwich-type ELISA. Measurable absorbance signals were obtained with 0.2 ng of L. intermedia crude venom per assay.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14757202     DOI: 10.1016/j.toxicon.2003.09.006

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  9 in total

1.  A camelid antibody candidate for development of a therapeutic agent against Hemiscorpius lepturus envenomation.

Authors:  Najmeh Yardehnavi; Mahdi Behdani; Kamran Pooshang Bagheri; Amir Mahmoodzadeh; Hossein Khanahmad; Delavar Shahbazzadeh; Mahdi Habibi-Anbouhi; Gholamreza Hassanzadeh Ghassabeh; Serge Muyldermans
Journal:  FASEB J       Date:  2014-06-02       Impact factor: 5.191

2.  First report of in vitro selection of RNA aptamers targeted to recombinant Loxosceles laeta spider toxins.

Authors:  Amalia Sapag; Catalina Salinas-Luypaert; Carlos Constenla-Muñoz
Journal:  Biol Res       Date:  2014-03-26       Impact factor: 5.612

3.  Generation and characterization of monoclonal antibody against Advanced Glycation End Products in chronic kidney disease.

Authors:  Alessandra Becker Finco; Ricardo Andrez Machado-de-Ávila; Rayana Maciel; Juliana De Moura; Philippe Billiald; Andrea Emilia Marques Stinghen; Larissa M Alvarenga
Journal:  Biochem Biophys Rep       Date:  2016-03-23

4.  Recombinant Protein Containing B-Cell Epitopes of Different Loxosceles Spider Toxins Generates Neutralizing Antibodies in Immunized Rabbits.

Authors:  Sabrina de Almeida Lima; Clara Guerra-Duarte; Fernanda Costal-Oliveira; Thais Melo Mendes; Luís F M Figueiredo; Daysiane Oliveira; Ricardo A Machado de Avila; Valéria Pereira Ferrer; Dilza Trevisan-Silva; Silvio S Veiga; João C Minozzo; Evanguedes Kalapothakis; Carlos Chávez-Olórtegui
Journal:  Front Immunol       Date:  2018-04-03       Impact factor: 7.561

Review 5.  Brown Spider (Loxosceles) Venom Toxins as Potential Biotools for the Development of Novel Therapeutics.

Authors:  Daniele Chaves-Moreira; Fernando Hitomi Matsubara; Zelinda Schemczssen-Graeff; Elidiana De Bona; Vanessa Ribeiro Heidemann; Clara Guerra-Duarte; Luiza Helena Gremski; Carlos Chávez-Olórtegui; Andrea Senff-Ribeiro; Olga Meiri Chaim; Raghuvir Krishnaswamy Arni; Silvio Sanches Veiga
Journal:  Toxins (Basel)       Date:  2019-06-19       Impact factor: 4.546

6.  Loxoscelism: Advances and Challenges in the Design of Antibody Fragments with Therapeutic Potential.

Authors:  Sabrina Karim-Silva; Alessandra Becker-Finco; Isabella Gizzi Jiacomini; Fanny Boursin; Arnaud Leroy; Magali Noiray; Juliana de Moura; Nicolas Aubrey; Philippe Billiald; Larissa M Alvarenga
Journal:  Toxins (Basel)       Date:  2020-04-16       Impact factor: 4.546

Review 7.  Prospective Use of Brown Spider Venom Toxins as Therapeutic and Biotechnological Inputs.

Authors:  Luiza Helena Gremski; Fernando Hitomi Matsubara; Nayanne Louise Costacurta Polli; Bruno Cesar Antunes; Pedro Henrique de Caires Schluga; Hanna Câmara da Justa; João Carlos Minozzo; Ana Carolina Martins Wille; Andrea Senff-Ribeiro; Silvio Sanches Veiga
Journal:  Front Mol Biosci       Date:  2021-06-17

Review 8.  Biotechnological Trends in Spider and Scorpion Antivenom Development.

Authors:  Andreas Hougaard Laustsen; Mireia Solà; Emma Christine Jappe; Saioa Oscoz; Line Præst Lauridsen; Mikael Engmark
Journal:  Toxins (Basel)       Date:  2016-07-23       Impact factor: 4.546

Review 9.  Venomous Arachnid Diagnostic Assays, Lessons from Past Attempts.

Authors:  Camila Dias-Lopes; Ana Luiza Paiva; Clara Guerra-Duarte; Franck Molina; Liza Felicori
Journal:  Toxins (Basel)       Date:  2018-09-10       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.